Obesity Interventions | Market Insights | US | 2023
Procedure deferrals due to the COVID-19 pandemic severely impacted the US obesity intervention market in 2020, and the elective nature of many postponed procedures hindered the pace of recovery to some extent. However, following the impact of the pandemic, the US obesity intervention market will grow modestly, driven by continuing growth in bariatric procedures, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features.
This Medtech 360 report provides comprehensive data and analysis on the state of the obesity intervention market in the US from 2019 through 2031.